Genentech Says It Shouldn't Lose Patent Rights Over Error
By Bonnie Eslinger ( March 26, 2020, 11:12 PM GMT) -- Genentech urged the Court of Appeal on Thursday to overlook a mistake made by one of its agents that threatens to prematurely end certain patent rights it has for its eye-disease treatment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.